%0 Journal Article
%T Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience.
%A Savchenko A
%A Targa G
%A Fesenko Z
%A Leo D
%A Gainetdinov RR
%A Sukhanov I
%J Biomolecules
%V 13
%N 5
%D 2023 05 9
%M 37238676
%F 6.064
%R 10.3390/biom13050806
%X The key element of dopamine (DA) neurotransmission is undoubtedly DA transporter (DAT), a transmembrane protein responsible for the synaptic reuptake of the mediator. Changes in DAT's function can be a key mechanism of pathological conditions associated with hyperdopaminergia. The first strain of gene-modified rodents with a lack of DAT were created more than 25 years ago. Such animals are characterized by increased levels of striatal DA, resulting in locomotor hyperactivity, increased levels of motor stereotypes, cognitive deficits, and other behavioral abnormalities. The administration of dopaminergic and pharmacological agents affecting other neurotransmitter systems can mitigate those abnormalities. The main purpose of this review is to systematize and analyze (1) known data on the consequences of changes in DAT expression in experimental animals, (2) results of pharmacological studies in these animals, and (3) to estimate the validity of animals lacking DAT as models for discovering new treatments of DA-related disorders.